Cargando…

The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China

BACKGROUND: With the recent certification by World Health Organization that the People’s Republic of China is malaria-free, it is timely to consider how elimination of malaria was completed in People’s Republic of China over the last 7 decades. Of the four widespread species of human malaria, Plasmo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guo-Jing, Shang, Le-Yuan, Zhou, Xiao-Nong, Lee, Tamsin E., Bi, Bo, White, Michael, Smith, Thomas A., Penny, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776510/
https://www.ncbi.nlm.nih.gov/pubmed/35057816
http://dx.doi.org/10.1186/s12916-021-02214-y
_version_ 1784636853493694464
author Yang, Guo-Jing
Shang, Le-Yuan
Zhou, Xiao-Nong
Lee, Tamsin E.
Bi, Bo
White, Michael
Smith, Thomas A.
Penny, Melissa A.
author_facet Yang, Guo-Jing
Shang, Le-Yuan
Zhou, Xiao-Nong
Lee, Tamsin E.
Bi, Bo
White, Michael
Smith, Thomas A.
Penny, Melissa A.
author_sort Yang, Guo-Jing
collection PubMed
description BACKGROUND: With the recent certification by World Health Organization that the People’s Republic of China is malaria-free, it is timely to consider how elimination of malaria was completed in People’s Republic of China over the last 7 decades. Of the four widespread species of human malaria, Plasmodium vivax was the last to be eliminated by the national program of China. Understanding the incubation periods and relapses patterns of P. vivax through historical data from China is relevant for planning disease elimination in other malaria-endemic countries, with residual P. vivax malaria. METHODS: We collated data from both published and unpublished malaria parasite inoculation experiments conducted between 1979 and 1988 with parasites from different regions of the People’s Republic of China. The studies had at least two years of follow-up. We categorized P. vivax incubation patterns via cluster analysis and investigated relapse studies by adapting a published within-host relapse model for P. vivax temperate phenotypes. Each model was fitted using the expectation-maximization (EM) algorithm initialized by hierarchical model-based agglomerative clustering. RESULTS: P. vivax parasites from the seven studies of five southern and central provinces in the People’s Republic of China covering geographies ranging from the south temperate to north tropical zones. The parasites belonged to two distinct phenotypes: short- (10–19 days) or long-incubation (228–371 days). The larger the sporozoite inoculation, the more likely short incubation periods were observed, and with more subsequent relapses (Spearman’s rank correlation between the number of inoculated sporozoites and the number of relapses of 0.51, p-value = 0.0043). The median of the posterior distribution for the duration of the first relapse interval after primary infection was 168.5 days (2.5% quantile: 89.7; 97.5% quantile: 227.69 days). The predicted survival proportions from the within-host model fit well to the original relapse data. The within-host model also captures the hypnozoite activation rates and relapse frequencies, which consequently influences the transmission possibility of P. vivax. CONCLUSIONS: Through a within-host model, we demonstrate the importance of clearance of hypnozoites. A strategy of two rounds of radical hypnozoite clearance via mass drug administration (MDA) deployed during transmission (summer and autumn) and non-transmission (late spring) seasons had a pronounced effect on outbreaks during the malaria epidemics in China. This understanding can inform malaria control strategies in other endemic countries with similar settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02214-y.
format Online
Article
Text
id pubmed-8776510
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87765102022-01-21 The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China Yang, Guo-Jing Shang, Le-Yuan Zhou, Xiao-Nong Lee, Tamsin E. Bi, Bo White, Michael Smith, Thomas A. Penny, Melissa A. BMC Med Research Article BACKGROUND: With the recent certification by World Health Organization that the People’s Republic of China is malaria-free, it is timely to consider how elimination of malaria was completed in People’s Republic of China over the last 7 decades. Of the four widespread species of human malaria, Plasmodium vivax was the last to be eliminated by the national program of China. Understanding the incubation periods and relapses patterns of P. vivax through historical data from China is relevant for planning disease elimination in other malaria-endemic countries, with residual P. vivax malaria. METHODS: We collated data from both published and unpublished malaria parasite inoculation experiments conducted between 1979 and 1988 with parasites from different regions of the People’s Republic of China. The studies had at least two years of follow-up. We categorized P. vivax incubation patterns via cluster analysis and investigated relapse studies by adapting a published within-host relapse model for P. vivax temperate phenotypes. Each model was fitted using the expectation-maximization (EM) algorithm initialized by hierarchical model-based agglomerative clustering. RESULTS: P. vivax parasites from the seven studies of five southern and central provinces in the People’s Republic of China covering geographies ranging from the south temperate to north tropical zones. The parasites belonged to two distinct phenotypes: short- (10–19 days) or long-incubation (228–371 days). The larger the sporozoite inoculation, the more likely short incubation periods were observed, and with more subsequent relapses (Spearman’s rank correlation between the number of inoculated sporozoites and the number of relapses of 0.51, p-value = 0.0043). The median of the posterior distribution for the duration of the first relapse interval after primary infection was 168.5 days (2.5% quantile: 89.7; 97.5% quantile: 227.69 days). The predicted survival proportions from the within-host model fit well to the original relapse data. The within-host model also captures the hypnozoite activation rates and relapse frequencies, which consequently influences the transmission possibility of P. vivax. CONCLUSIONS: Through a within-host model, we demonstrate the importance of clearance of hypnozoites. A strategy of two rounds of radical hypnozoite clearance via mass drug administration (MDA) deployed during transmission (summer and autumn) and non-transmission (late spring) seasons had a pronounced effect on outbreaks during the malaria epidemics in China. This understanding can inform malaria control strategies in other endemic countries with similar settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02214-y. BioMed Central 2022-01-21 /pmc/articles/PMC8776510/ /pubmed/35057816 http://dx.doi.org/10.1186/s12916-021-02214-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Guo-Jing
Shang, Le-Yuan
Zhou, Xiao-Nong
Lee, Tamsin E.
Bi, Bo
White, Michael
Smith, Thomas A.
Penny, Melissa A.
The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
title The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
title_full The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
title_fullStr The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
title_full_unstemmed The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
title_short The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
title_sort empirical support for the radical cure strategy for eliminating plasmodium vivax in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776510/
https://www.ncbi.nlm.nih.gov/pubmed/35057816
http://dx.doi.org/10.1186/s12916-021-02214-y
work_keys_str_mv AT yangguojing theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT shangleyuan theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT zhouxiaonong theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT leetamsine theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT bibo theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT whitemichael theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT smiththomasa theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT pennymelissaa theempiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT yangguojing empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT shangleyuan empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT zhouxiaonong empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT leetamsine empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT bibo empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT whitemichael empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT smiththomasa empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina
AT pennymelissaa empiricalsupportfortheradicalcurestrategyforeliminatingplasmodiumvivaxinchina